Effects of sodium/glucose cotransporter 2 inhibitors on the coagulation profile in patients with coronary-artery disease and type 2 diabetes mellitus: a retrospective cohort study
SGLT2is could affect coagulation function by prolonging coagulation time and increasing anticoagulatory activity in patients with T2DM and CAD. These drugs could be used to ameliorate hypercoagulable states and reduce thrombosis risk in these patients.
Authors
- Ge Song (ORCID: https://orcid.org/0000-0002-1118-1850)
- Xuejun Qin (ORCID: https://orcid.org/0000-0001-9169-253X)
Institutions
- First Hospital of Shijiazhuang (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-05-07
- DOI
- https://doi.org/10.3389/fcvm.2025.1588797
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29